Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, or acquiring noninvasive technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a medical device in Canada for the treatment of chronic balance deficit associated with a mild to moderate traumatic brain injury. Its PoNS device treats neurostimulation of cranial nerves via the tongue to restore lost function. Helius Medical Technologies, Inc. is headquartered in Newtown, Pennsylvania.
Industry, Sector and Symbol
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone215-944-6100
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesC$1.82 million
Profitability
Miscellaneous
Employees25
Next Earnings Date3/12/2020 (Confirmed)
OptionableNot Optionable
Helius Medical Technologies (TSE:HSM) Frequently Asked Questions
What is Helius Medical Technologies' stock symbol?
Helius Medical Technologies trades on the Toronto Stock Exchange (TSX) under the ticker symbol "HSM."
When is Helius Medical Technologies' next earnings date?
Has Helius Medical Technologies been receiving favorable news coverage?
News coverage about HSM stock has been trending very negative recently, according to InfoTrie. The research firm rates the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Helius Medical Technologies earned a media sentiment score of -3.8 on InfoTrie's scale. They also gave news articles about the company a news buzz of 8.0 out of 10, indicating that recent press coverage is very likely to have an impact on the stock's share price in the near term. View News Stories for Helius Medical Technologies.
Who are some of Helius Medical Technologies' key competitors?
Some companies that are related to Helius Medical Technologies include Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB (IMR), Hamilton Thorne (HTL), Cyclopharm (CYC), Advanced Oncotherapy (AVO), Electromed (ELMD), Electromed (ELMD), Kromek Group (KMK), MRI Interventions (MRIC), Patient Home Monitoring (PTQ), REVA Medical (RVA), Impedimed (IPD), Avacta Group (AVCT), EMvision Medical Devices (EMV), Protech Home Medical (PHM) and Oventus Medical (OVN).
What other stocks do shareholders of Helius Medical Technologies own?
Who are Helius Medical Technologies' key executives?
Helius Medical Technologies' management team includes the folowing people:
- Mr. Philippe Deschamps, Chairman, CEO & Pres (Age 57)
- Ms. Joyce N. LaViscount, CFO & COO (Age 57)
- Ms. Jennifer Laux M.B.A., Chief Commercialization Officer (Age 52)
- Dr. Jonathan Mark Sackier, Chief Medical Officer (Age 61)
- Diane Carman, Sec.
How do I buy shares of Helius Medical Technologies?
Shares of HSM and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Helius Medical Technologies' stock price today?
One share of HSM stock can currently be purchased for approximately C$1.20.
How big of a company is Helius Medical Technologies?
What is Helius Medical Technologies' official website?
How can I contact Helius Medical Technologies?
The company can be reached via phone at 215-944-6100.
MarketBeat Community Rating for Helius Medical Technologies (TSE HSM)
MarketBeat's community ratings are surveys of what our community members think about Helius Medical Technologies and other stocks. Vote "Outperform" if you believe HSM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HSM will underperform the S&P 500 over the long term. You may vote once every thirty days.
